The Institute of Microbiology at the Chinese Academy of Sciences (IMCAS) announced that its application for fully human monoclonal antibody clinical trials targeting COVID-19 has…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.